Hims Hers Snaps Losing Streak as EPS Beat Fails Again
Hims & Hers beat quarterly EPS but trimmed full-year guidance, extending a slide in its stock as regulatory headwinds...
Watch Out Budget Categories
Learn how to identify key budget categories and monitor them effectively. A concise guide to staying on top of your spending and maximizing savings.
24,745 articles
Crypto Price Prediction Today: XRP, Solana, Bitcoin Rally Sparks Fresh Bets
Bitcoin regained key support as XRP and Solana join a broader market rally fueled by regulatory clarity and instituti...
Why Upwork Stock Down This Year Is So Hard to Read
Upwork stock has fallen this year as a big investor sold a multi-million stake, raising questions about the company’s...
Warner/Paramount Sets Hollywood Shrink: Big Four Emerges
Paramount has emerged as the apparent victor in a months-long bidding war to buy Warner Bros. Discovery’s film and TV...
Nasdaq Composite Volatility Spikes 18% on US-Iran Front
Geopolitical tensions trigger a broad 18% intraday volatility spike in the Nasdaq Composite, rattling tech names and ...
Cavco Stock Year Fund Signals Value Over 12 Months
Cavco stock rose about 9% over the past year even as a large fund pulled roughly $12 million in Cavco shares. This ar...
Equal-Weight S&P 500 Quietly Crushing the Market in 2026
In 2026, the equal-weight S&P 500 index has posted impressive breadth-driven gains, outpacing the cap-weight S&P 500 ...
Peter Thiel Warned Coming: Banks Embrace AI-Driven Cuts
A wave of AI-driven efficiency moves is prompting banks to trim payrolls. The trend rekindles a widely circulated war...
Freshworks Executive Sold Over: Is FRSH Stock a Buy?
An insider stake moved when a Freshworks executive sold over 32,577 shares for roughly $275,000. This article breaks ...
Morgan Stanley Warns Breakthrough Could Hit AI in 2026
A major bank projects a transformative AI leap in 2026, with wide-ranging impacts on markets, energy grids, and perso...
Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Down 20%, Oracle No-Brainer AI Buy: A Practical Guide
Oracle slipped this year, but does that mean it's a no-brainer AI buy? This practical guide weighs AI potential, fina...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status